Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for refractory tuberculous meningitis
ChiCTR2000035500Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thalidomide in meningeal tuberculosis (2 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoints: Clinical symptoms, Cerebrospinal fluid biochemical indicators and 4 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
meningeal tuberculosis
Beyond the preview
Go deeper on ChiCTR2000035500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035500.